Pure Global
NCT02719145

Circulating Micro RNAs Expression in Egyptian Bronchial Asthma and COPD Patients

Tanta University·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Asthma,COPD
Study type
Observational
Sponsor & location
Primary sponsor
Tanta University
Location
Tanta, Egypt
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2015
End date
Sep 01, 2016
Enrollment
30 participants
Primary outcome

miR-7, miR-20a, miR-21, miR-22, miR-145 and miR-155 in serum samples from control, asthma and COPD Egyptian subjects.

Summary

This cross sectional study will be carried out on 30 subjects who will be recruited from the
 outpatient clinic of Chest Department, Tanta University Hospital.
 
 They will be classified into 3 groups:
 
 Group I: It will include 10 healthy volunteer subjects. Group II: It will include 10
 asthmatic patients. Group III: It will include 10 COPD patients. miR-7, miR-20a, miR-21,
 miR-22, miR-145 and miR-155 will be measured in serum samples from all subjects

ICD-10 classifications
AsthmaAsthma, unspecifiedNonallergic asthmaMixed asthmaOther chronic obstructive pulmonary disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02719145
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT02719145 through Pure Global AI's free database. This phase not specified trial is sponsored by Tanta University and is currently Completed. The study focuses on Asthma,COPD. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.